{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:41:13Z","timestamp":1773236473639,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.sleepx.2025.100149","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:47:48Z","timestamp":1758829668000},"page":"100149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1738-3629","authenticated-orcid":false,"given":"Motohiro","family":"Ozone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunari","family":"Habukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hiejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Kotorii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Murotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurie","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Koebis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Taninaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleepx.2025.100149_bib1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.sleep.2009.07.008","article-title":"Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the international classification of sleep disorders (ICSD)","volume":"10","author":"Ohayon","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sleep.2016.05.013","article-title":"Nationwide epidemiological study of insomnia in Japan","volume":"25","author":"Itani","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.30773\/pi.2021.0344","article-title":"Mediation effect of insomnia symptoms on relation between stress and quality of life","volume":"19","author":"Lee","year":"2022","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.sleepx.2025.100149_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleepx.2025.100149_bib6","article-title":"Pharmacotherapy for insomnia in primary care","volume":"18","author":"Smith","year":"2016","journal-title":"Prim Care Comp CNS Disord"},{"key":"10.1016\/j.sleepx.2025.100149_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M15-1781","article-title":"Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American college of physicians","volume":"165","author":"Wilt","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib8","first-page":"964","article-title":"GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics","volume":"56","author":"Siriwardena","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.sleepx.2025.100149_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.9758\/cpn.2014.12.2.128","article-title":"Prescription patterns for patients with schizophrenia in Korea: a focus on antipsychotic polypharmacy","volume":"12","author":"Kim","year":"2014","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.sleepx.2025.100149_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.775144","article-title":"Association between Z drugs use and risk of cognitive impairment in middle-aged and older patients with chronic insomnia","volume":"15","author":"Guo","year":"2021","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.sleepx.2025.100149_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40266-015-0251-3","article-title":"Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US medicare perspective","volume":"32","author":"Tannenbaum","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sleepx.2025.100149_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.psychres.2015.11.003","article-title":"Prevalence and associated factors of hypnotics dependence among Japanese outpatients with psychiatric disorders","volume":"230","author":"Murakoshi","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.sleepx.2025.100149_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14740338.2019.1657091","article-title":"Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey","volume":"18","author":"Sano","year":"2019","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.sleepx.2025.100149_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/npr2.12069","article-title":"Suvorexant for insomnia in patients with psychiatric disorder: a 1-week, open-label study","volume":"39","author":"Kishi","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.sleepx.2025.100149_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fpsyt.2020.00444","article-title":"Comparisons between successful versus unsuccessful switches from benzodiazepines or zolpidem (Z-Drug) to controlled-release melatonin in patients with major depressive disorder and insomnia","volume":"11","author":"An","year":"2020","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.sleepx.2025.100149_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.9758\/cpn.2018.16.2.184","article-title":"Assessment of switching to suvorexant versus the use of add-on suvorexant in combination with benzodiazepine receptor agonists in insomnia patients: a retrospective study","volume":"16","author":"Hatano","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.sleepx.2025.100149_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2868","article-title":"Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma-aminobutyric acid-benzodiazepine receptor agonists or suvorexant","volume":"38","author":"Okino","year":"2023","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.sleepx.2025.100149_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajp.2017.04.010","article-title":"Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia","volume":"29","author":"Suzuki","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.sleepx.2025.100149_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211039098","article-title":"The effect of lemborexant for insomnia disorder","volume":"9","author":"Suzuki","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5664\/jcsm.10946","article-title":"A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists","volume":"20","author":"Tachibana","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib22","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1002\/pcn5.32","article-title":"Low-dose benzodiazepine receptor agonists May be completely replaced by lemborexant at about the same dose","volume":"1","author":"Usui","year":"2022","journal-title":"PCN Rep"},{"key":"10.1016\/j.sleepx.2025.100149_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1007\/s12325-024-02811-2","article-title":"Efficacy and safety of transitioning to lemborexant from z-drug, suvorexant, and ramelteon in Japanese insomnia patients: an open-label, multicenter study","volume":"41","author":"Ozone","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.sleepx.2025.100149_bib24","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.sleepx.2025.100149_bib25","unstructured":"Eisai Co., Ltd. Japanese package insert of DAYVIGO (lemborexant). https:\/\/medical2.eisai.jp\/fileviewer\/pdf_downloader.php?access_key=5tjaftxsj12024 (accessed 30 December 2024)."},{"key":"10.1016\/j.sleepx.2025.100149_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia severity index as an outcome measure for insomnia research","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib27","series-title":"Manual of the SF-8 Japanese version: qualitest","first-page":"2021","author":"Fukuhara","year":"2004"},{"key":"10.1016\/j.sleepx.2025.100149_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sleep.2016.04.011","article-title":"Later sleep schedule and depressive symptoms are associated with usage of multiple kinds of hypnotics","volume":"25","author":"Shimura","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.sleep.2014.11.018","article-title":"Impact of hypnotics use on daytime function and factors associated with usage by female shift work nurses","volume":"16","author":"Futenma","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1086-5802(15)30354-5","article-title":"Management of insomnia","volume":"39","author":"Kirkwood","year":"1999","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.1016\/j.sleepx.2025.100149_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleepx.2025.100149_bib32","unstructured":"Pharmaceuticals and medical devices agency. Alert for proper use of drugs. Updated May 2024. https:\/\/www.pmda.go.jp\/files\/000268322.pdf."},{"key":"10.1016\/j.sleepx.2025.100149_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.sleepx.2025.100149_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.sleep.2021.01.048","article-title":"Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial","volume":"80","author":"Yardley","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2025.100149_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18254","article-title":"Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial","volume":"2","author":"Rosenberg","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sleepx.2025.100149_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa123","article-title":"Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2","volume":"43","author":"K\u00e4rpp\u00e4","year":"2020","journal-title":"Sleep"}],"container-title":["Sleep Medicine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142725000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142725000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:36:39Z","timestamp":1773164199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590142725000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"alternative-id":["S2590142725000126"],"URL":"https:\/\/doi.org\/10.1016\/j.sleepx.2025.100149","relation":{},"ISSN":["2590-1427"],"issn-type":[{"value":"2590-1427","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleepx.2025.100149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100149"}}